| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -501 K | 100% | $40.10 | -$20.1 M |
| Net | -5 | -501 K | -100% | -$20.1 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Yujiro Hata | President and CEO, Director | $28.7 M | -$17.6 M | -37.9% | May 14, 2024 |
| Michael P. Dillon | SVP, Chief Scientific Officer | $3.31 M | Oct 4, 2021 | ||
| Andres Ruiz | Title: SVP, Head of Finance and Investor Relations | $1.13 M | -$380 K | -25.2% | Mar 1, 2024 |
| Jason Throne | Chief Legal Officer | $445 K | -$776 K | -63.6% | Jun 27, 2024 |
| Paul A. Stone | Chief Financial Officer | $391 K | -$339 K | -46.4% | Aug 29, 2023 |
| Michael Anthony White | Chief Scientific Officer | $0 | -$1.03 M | -100% | May 29, 2024 |
| Timothy M. Shannon | Director | Jun 7, 2023 | |||
| Susan L. Kelley | Director | May 31, 2024 | |||
| Malcolm Garret Hampton | Director | May 31, 2024 | |||
| Terry J. Rosen | Director | May 31, 2024 | |||
| Jeffrey Stein | Director | May 31, 2024 | |||
| Catherine J. Mackey | Director | May 31, 2024 | |||
| Darrin Beaupre | Chief Medical Officer | Mar 1, 2024 | |||
| Scott W. Morrison | Director | May 31, 2024 | |||
| Wendy L. Yarno | Director | May 31, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|